Skip to Main Content

Paper Details

Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE).
J Int AIDS Soc
7
2022
Author NameAffiliation
Maggie Czarnogorski
Leandro MenaUniversity of Mississippi Medical Center
Jason FlammKaiser Permanente Sacramento
  • 1 - 3

Datasets

Release 1.2